STAA
STAAR Surgical CompanyNASDAQHealthcare$20.21+4.55%ClosedMarket Cap: $1.00B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.91
P/S
4.18
EV/EBITDA
-23.64
DCF Value
$1.12
FCF Yield
-4.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.6%
Operating Margin
-33.3%
Net Margin
-33.6%
ROE
-23.2%
ROA
-18.7%
ROIC
-19.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $57.8M | 73.4% | $-10.9M | $-18.3M | $-0.36 | — |
| FY 2025 | $239.4M | 73.9% | $-45.9M | $-80.4M | $-1.62 | — |
| Q3 2025 | $94.7M | 82.2% | $18.5M | $8.9M | $0.18 | — |
| Q2 2025 | $44.3M | 74.0% | $-30.0M | $-16.8M | $-0.34 | — |
| Q1 2025 | $42.6M | 65.8% | $-57.4M | $-54.2M | $-1.10 | — |
| Q4 2024 | $49.0M | 64.7% | $-27.9M | $-34.2M | $-0.69 | — |
| FY 2024 | $313.9M | 76.3% | $-12.6M | $-20.2M | $-0.41 | — |
| Q3 2024 | $88.6M | 77.3% | $5.7M | $10.0M | $0.20 | — |
| Q2 2024 | $99.0M | 79.2% | $11.9M | $7.4M | $0.15 | — |
| Q1 2024 | $77.4M | 78.9% | $-2.3M | $-3.3M | $-0.07 | — |
| Q4 2023 | $76.3M | 79.6% | $10.4M | $7.8M | $0.16 | — |
| FY 2023 | $322.4M | 78.4% | $28.1M | $21.3M | $0.43 | — |